Keywords: رومیپلاستیم; Eltrombopag; rituximab; romiplostim; thrombocytopenia; thrombopoietin;
مقالات ISI رومیپلاستیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رومیپلاستیم; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Romiplostim; Immune thrombocytopenia;
Keywords: رومیپلاستیم; Eltrombopag; Leukemia; rHuMGDF; Romiplostim; Thrombopoietin; Supportive care; TPO; MDS;
Keywords: رومیپلاستیم; Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Ensayo clínico aleatorizado controlado; Romiplostim; Trombocitopenia; Tromboembolismo; Trombosis; Trombopoyetina
Keywords: رومیپلاستیم; Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Ensayo clínico aleatorizado controlado; Romiplostim; Trombocitopenia; Tromboembolismo; Trombosis; Trombopoyetina
Keywords: رومیپلاستیم; AIHA; autoimmune hemolytic anemia; ASH; American Society of Hematology; CLL; chronic lymphocytic leukemia; CMV; cytomegalovirus; CVID; common variable immunodeficiency; GPRD; General Practice Research Database; DIC; disseminated intravascular coagulation;
Keywords: رومیپلاستیم; Immune thrombocytopenia; Rituximab; Eltrombopag; Romiplostim; Splenectomy; Thrombosis
Article originalThromboses sous agonistes du récepteur de la thrombopoïétine au cours du purpura thrombopénique immunologique. Ãtude rétrospective multicentrique en FranceThrombosis during thrombopoietin receptor agonist treatment for immune thrombo
Keywords: رومیپلاستیم; Thrombopénie immunologique; Thromboses; Agoniste du récepteur de la thrombopoïétine; Romiplostim; Eltrombopag; Immune thrombocytopenia; Thrombosis; Thrombopoietin receptor agonist; Romiplostim; Eltrombopag;
Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales
Keywords: رومیپلاستیم; chronic immune thrombocytopenia; cost-effectiveness; eltrombopag; indirect treatment comparison; romiplostim; thrombopoietin receptor agonist;
THPO–MPL pathway and bone marrow failure
Keywords: رومیپلاستیم; THPO (Thrombopoietin); MPL (myeloproliferative leukemia virus); JAK (Janus Kinase); CALR (calreticulin); Aplastic anemia; Bone marrow failure; Thrombocythemia; Myelofibrosis; Eltrombopag; Romiplostim
Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España
Keywords: رومیپلاستیم; Púrpura trombocitopénica idiopática; Costes y análisis de costes; Rituximab; RomiplostimIdiopathic thrombocytopenic purpura; Costs and costs analysis; Rituximab; Romiplostim
Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain
Keywords: رومیپلاستیم; Idiopathic thrombocytopenic purpura; Costs and costs analysis; Rituximab; RomiplostimPúrpura trombocitopénica idiopática; Costes y análisis de costes; Rituximab; Romiplostim
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009–2013 French PharmacoVigilance assessment
Keywords: رومیپلاستیم; Thrombopoietin receptor agonist; Romiplostim; Eltrombopag; Adverse drug reaction; Pharmacovigilance; Disproportionality analysis
The new thrombopoietic agenda: Impact on leukemias and MDS
Keywords: رومیپلاستیم; thrombopoeitin receptor agonists; romiplostim; eltrombopag; myelodysplastic syndromes; MDS; acute myeloid leukemia; AML; immune thrombocytopenia; ITP; TPO
Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials
Keywords: رومیپلاستیم; Eltrombopag; Meta-analysis; Randomized controlled trials; Romiplostim; Thromboembolism; Thrombosis; ThrombocytopeniaEltrombopag; Metaanálisis; Ensayo clínico aleatorizado y controlado; Romiplostim; Tromboembolia; Trombosis; Trombocitopenia
Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)
Keywords: رومیپلاستیم; EQ-5D; Immune thrombocytopenia; Romiplostim; Utility
Thrombopoietic agents
Keywords: رومیپلاستیم; ITP, immune thrombocytopenic purpura; TPO, thrombopoietinThrombopoietin; Thrombopoietin receptor agonists; Romiplostim; Eltrombopag; Thrombocytopenia